Are you sure?

GlaxoSmithKline to set up €100 mln vaccine plant in Hungary

GlaxoSmithKline, one of Hungary's largest investors in the drugs industry, is to set up a high-tech vaccine production facility in Gödöllõ, 30 kilometers northeast of Budapest. GSK's €100 million investment is one of the company's key strategic investments in Europe. The new facility will apply the latest technological solutions and deliver the vaccines all over the world. The plant will be inaugurated on September 8. GSK has a staff of 360 people in Hungary. GlaxoSmithKline is to spend over Ft 22 billion (€79.5 million) to upgrade vaccine production capacities at its Gödöllõ facility that it bought from Human Rt. The regional R&D centre has an annual budget of Ft 370 million (€1.34 million) and involves 1,300 patients. The investment volume as well as the number of R&D patients are to be more than doubled by 2007. (MTI-Eco)